PHENOTYPIC CHARACTERISTICS OF ANDROGEN RECEPTOR-POSITIVE CANCER IN THE TRIPLE-NEGATIVE BREAST CANCER GROUP

Author:

Panchenko Ivan Sergeevich1ORCID,Rodionov Valery Vitalievich2ORCID,Panchenko Sergey Viktorovich1ORCID,Sharafutdinov Marat Gakifovich1ORCID

Affiliation:

1. Ulyanovsk State University

2. Gynecology and Perinatology named after academician V.I. Kulakov, Ministry of Health of the Russian Federation

Abstract

The aim of the paper is to reveal the phenotypic characteristics of androgen-receptor-positive breast cancer in triple-negative breast cancer. Materials and Methods. The authors analyzed clinical and morphological tumour data in 253 patients with morphologically verified invasive triple-negative breast cancer (TNBC). The patients were treated at the Regional Clinical Oncologic Dispensary (Ulyanovsk) and the Breast Pathology Department of the National Medical Research Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov (Moscow) from 2014 to 2021. Results. Statistical analysis of 45 patients (18 % of the total sample) showed that androgen receptor (AR) expression in TNBC was observed in patients older than 61 years (p=0.054). It was associated with a more common stage of the disease (starting with IIB) (p=0.004), multifocal growth pattern (p=0.025), invasive lobular cancer (p=0.04), higher tumor differentiation (p<0.0001), low Ki67 level (p=0.000001), and more frequent involvement of regional lymph nodes (p=0.005). At the same time, there were no statistically significant correlations between the AR expression and menstrual function, breast lesion quadrant, and pathomorphological response after neoadjuvant polychemotherapy. Conclusion. AR expression in TNBC occurs in patients over 61 years of age, with a locally advanced disease stage, a multifocal tumor growth pattern, an invasive lobular cancer, and well-differentiated tumors with low proliferative activity.

Publisher

Ulyanovsk State University

Reference29 articles.

1. Katrina R. Bauer, Monica Brown, Rosemary D. Cress, Carol A. Parise, Vincent Caggiano. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer. 2007; 109 (9): 1721–1728. Available at: https://pubmed.ncbi.nlm.nih.gov/17387718 (accessed: April 07, 2021). DOI: 10.1002/cncr.22618.

2. Rebecca Dent, Maureen Trudeau, Kathleen I. Pritchard, Wedad M. Hanna, Harriet K. Kahn, Carol A. Sawka, Lavina A. Lickley, Ellen Rawlinson, Ping Sun, Steven A. Narod. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin. Cancer Res. 2007; 13 (15, Pt. 1): 4429–4434. Available at: https://pubmed.ncbi.nlm.hih.gov/17671126 (accessed: April 07, 2021). DOI: 10.1158/1078-0432.CCR-06-3045.

3. Maryam Nakhjavani, Jennifer E Hardingham, Helen M. Palethorpe, Tim J. Price, Amanda R. Townsend. Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer. J. Breast Cancer. 2019; 22 (3): 341–361. Available at: https://pubmed.ncbi.nlm.nih.gov/31598336 (accessed: April 07, 2021). DOI: 10.4048/jbc.2019.22.e39.

4. Alis R. T. Bergin, Sherene Loi. Triple-negative breast cancer: recent treatment advances. F1000Res. 2019; 8: F1000 Faculty Rev-1342. Available at: https:// pubmed.ncbi.nlm.nih.gov/31448088 (accessed: April 16, 2021). DOI: 10.12688/f1000research.18888.1.

5. Brain D. Lehmann, Bojana Jovanovic, Xi Chen, Monica V. Estrada, Kimberly N. Johnson, Yu Shyr, Harold L. Moses, Melinda E. Sanders, Jennifer A. Pietenpol. Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection. PLoS One. 2016; 11 (6): e0157368. Available at: https://pubmed.ncbi.nlm.nih.gov/27310713 (accessed: April 07, 2021). DOI: 10.1371/journal.pone.0157368.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3